VISIUM TECHNOLOGIES INC
For the period ended Dec 31, 2023. Filed Feb 20, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Dec 31, 2023 · Filed Feb 20, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Notes to Consolidated Financial Statements (unaudited)
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 1: ORGANIZATION, GOING CONCERN AND BASIS OF PRESENTATION
Visium Technologies, Inc. is focused on professional technology services, digital risk management, and cybersecurity for network physical security, the Cloud, mobility solutions, critical infrastructure security, and the Internet of Things (“IOT”).
In April 2021 the Company created JAJ Advisory, LLC, a Viriginia limited liability company. The LLC was established to account for non-technology/cybersecurity related business activities that the Company may pursue.
Recent Developments
The Company is entering the West Africa data center construction market after it landed a contract valued at over $20 million from its partner, Cybastion Institute of Technology, to oversee the design and construction of data centers in the Republic of Côte d’Ivoire and the Republic of Benin. Visium is tasked with creating data centers that meet specific requirements and standards, ensuring optimal performance and reliability. The scope of work includes data center architecture and design, power controls and distribution systems, rack layouts, network topology, vendor high availability, and a comprehensive security stack which will includes Visium’s proprietary TruContext TM cybersecurity platform.
Going Concern
The accompanying consolidated financial statements have been prepared on a going concern basis. For the six months ended December 31, 2023 we had a net loss of $1,797,007, had net cash used in operating activities of $267,208 and had negative working capital of $4,724,913. These matters raise substantial doubt about the Company’s ability to continue as a going concern for a period of one year from the date of this filing. The Company’s ability to continue as a going concern is dependent upon its ability to obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due, to fund possible future acquisitions, and to generate profitable operations in the future. Management plans to provide for the Company’s capital requirements by continuing to issue additional equity and debt securities. The outcome of these matters cannot be predicted at this time and there are no assurances that, if achieved, the Company will have sufficient funds to execute its business plan or generate positive operating results. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.
Basis of Presentation
The unaudited interim consolidated financial information furnished herein reflects all adjustments, consisting only of normal recurring items, which in the opinion of management are necessary to fairly state Visium Technologies, Inc.’s (the “Company” or “we”, “us” or “our”) financial position, results of operations and cash flows for the dates and periods presented and to make such information not misleading. Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been omitted pursuant to rules and regulations of the United States Securities and Exchange Commission (“SEC”), nevertheless, management of the Company believes that the disclosures herein are adequate to make the information presented not misleading.
These unaudited consolidated financial statements should be read in conjunction with the Company’s audited financial statements for the year ended June 30, 2023, contained in the Company’s Annual Report on Form 10-K filed with the SEC on October 6, 2023. The results of operations for the six months ended December 31, 2023, are not necessarily indicative of results to be expected for any other interim period or the fiscal year ending June 30, 2024.
NOTE 2: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Fiscal Year
The fiscal year ends on June 30. References to fiscal year 2024, for example, refer to the fiscal year ending June 30, 2024.
Principles of Consolidation
The accompanying unaudited consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles and include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany transactions and balances have been eliminated in consolidation.
Use of Estimates
The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reporting amounts of revenues and expenses during the reported period. Actual results will differ from those estimates. Included in these estimates are assumptions used in Cox, Ross & Rubinstein Binomial Tree stock-based compensation valuation methods, such as expected volatility, risk-free interest rate, and expected dividend rate and in the valuation allowance of deferred tax assets and derivative liability.
Cash and Cash Equivalents
The Company considers all highly liquid, temporary, cash equivalents or investments with an original maturity of three months or less when purchased, to be cash equivalents. The Company had no cash equivalents during the six months ended December 31, 2023 and year ended June 30, 2023.
Concentration of Credit Risks
The Company is subject to a concentration of credit risk from cash.
The Company’s cash account is held at a financial institution and is insured by the Federal Deposit Insurance Corporation, or FDIC, up to $250,000. As of December 31, 2023 and June 30, 2023, the Company did not exceed these FDIC limits.
Derivative Liabilities
The Company assessed the classification of its derivative financial instruments as of December 31, 2023 and June 30, 2023 which consist of convertible instruments and rights to shares of the Company’s common stock and determined that such derivatives meet the criteria for liability classification under ASC 815.
ASC 815 generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument subject to the requirements of ASC 815. ASC 815 also provides an exception to this rule when the host instrument is deemed to be conventional, as described.
The Company uses judgment in determining the fair value of derivative liabilities at the date of issuance and at every balance sheet thereafter and in determining which valuation method is most appropriate for the instrument, the expected volatility, the implied risk-free interest rate, as well as the expected dividend rate, if any. The Company recorded derivative liabilities as of December 31, 2023 of $48,018.
Fair Value of Financial Instruments
The Company accounts for assets and liabilities measured at fair value on a recurring basis, in accordance with ASC Topic 820, Fair Value Measurements and Disclosures, or ASC 820. ASC 820 establishes a common definition for fair value to be applied to existing generally accepted accounting principles that require the use of fair value measurements, establishes a framework for measuring fair value, and expands disclosure about such fair value measurements.
ASC 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Additionally, ASC 820 requires the use of valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs. These inputs are prioritized below:
| Level 1: | Observable inputs such as quoted market prices in active markets for identical assets or liabilities. |
|---|---|
| Level 2: | Observable market-based inputs or unobservable inputs that are corroborated by market data. |
| Level 3: | Unobservable inputs for which there is little or no market data, which require the use of the reporting entity’s own assumptions. |
Additional Disclosures Regarding Fair Value Measurements
The carrying value of cash, accounts payable and accrued expenses, accrued compensation, notes payable and convertible promissory notes payable, approximate their fair value due to the short maturity of these items or the use of market interest rates.
Convertible Instruments
The Company accounts for convertible instruments (when it has determined that the embedded conversion options should not be bifurcated from their host instruments) in accordance with ASC 470-20, Debt with Conversion and Other Options. Accordingly, the Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their earliest date of redemption. The Company also records deemed dividends for the intrinsic value of conversion options embedded in preferred shares based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note.
ASC 815-40, Contracts in Entity’s own Equity, generally provides that, among other things, if an event is not within the entity’s control, such contract could require net cash settlement and shall be classified as an asset or a liability.
The Company determines whether the instruments issued in the transactions are considered indexed to the Company’s own stock. During fiscal years 2014 through 2023 the Company’s issued convertible securities with variable conversion provisions that resulted in derivative liabilities. See discussion above under derivative liabilities that resulted in a change in derivative liability accounting.
Revenue Recognition
All revenues are recorded in accordance with ASC 606, which is recognized when: (i) a contract with a client has been identified, (ii) the performance obligation(s) in the contract have been identified, (iii) the transaction price has been determined, (iv) the transaction price has been allocated to each performance obligation in the contract, and (v) the Company has satisfied the applicable performance obligation over time.
Income Taxes
The Company accounts for income taxes pursuant to the provisions of ASC 740-10, “Accounting for Income Taxes,” which requires, among other things, an asset and liability approach to calculating deferred income taxes. The asset and liability approach requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the carrying amounts and the tax bases of assets and liabilities. A valuation allowance is provided to offset any net deferred tax assets for which management believes it is more likely than not that the net deferred asset will not be realized.
The Company follows the provisions of ASC 740-10, “Accounting for Uncertain Income Tax Positions”. When tax returns are filed, it is highly certain that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained. In accordance with the guidance of ASC 740-10, the benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above should be reflected as a liability for uncertain tax benefits in the accompanying balance sheet along with any associated interest and penalties that would be payable to the taxing authorities upon examination. The Company believes its tax positions are all highly certain of being upheld upon examination. As such, the Company has not recorded a liability for uncertain tax benefits.
The Company has adopted ASC 740-10-25,“Definition of Settlement”, which provides guidance on how an entity should determine whether a tax position is effectively settled for the purpose of recognizing previously unrecognized tax benefits and provides that a tax position can be effectively settled upon the completion of an examination by a taxing authority without being legally extinguished. For tax positions considered effectively settled, an entity would recognize the full amount of tax benefit, even if the tax position is not considered more likely than not to be sustained based solely on the basis of its technical merits and the statute of limitations remains open. As of December 31, 2023, the Company had not filed tax returns for the tax years ending June 30, 2008 through 2023 and such returns, when filed, potentially will be subject to audit by the taxing authorities for a minimum of three years beyond the filing date under the three-year statute of limitations. The Company has not accrued any potential tax penalties associated with not filing these tax returns. Due to recurring losses, management believes such potential tax penalties, if any, would not be material in amount.
Share-Based Payments
The Company accounts for stock-based compensation in accordance with ASU 2022-07, Compensation – Stock Compensation (Topic 718). This update is intended to reduce cost and complexity and to improve financial reporting for share-based payments issued to non-employees (for example, service providers, external legal counsel, suppliers, etc.). The ASU expands the scope of Topic 718, Compensation—Stock Compensation, which currently only includes share-based payments issued to employees, to also include share-based payments issued to non-employees for goods and services. Consequently, the accounting for share-based payments to non-employees and employees is substantially aligned.
Under ASC Topic 718, “Compensation – Stock Compensation”. Under the fair value recognition provisions of this topic, stock-based compensation cost is measured at the grant date based on the fair value of the award and is recognized as an expense on a straight-line basis over the requisite service period, which is the vesting period.
The Company has elected to use the Cox, Ross & Rubinstein Binomial Tree valuation model to estimate the fair value of its options, which incorporates various subjective assumptions including volatility, risk-free interest rate, expected life, and dividend yield to calculate the fair value of stock option awards. Compensation expense recognized in the statements of operations is based on awards ultimately expected to vest and reflects estimated forfeitures. ASC 718 requires forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.
Segment Reporting
The Company operates in one business segment which technologies are focused on professional services, data analytics, and cybersecurity.
Recent Accounting Pronouncements
All new accounting pronouncements issued but not yet effective are not expected to have a material impact on our results of operations, cash flows or financial position. There have been no new accounting pronouncements not yet effective that have significance to our consolidated financial statements.
Basic and Diluted Earnings Per Share
Basic earnings per share are calculated by dividing income available to stockholders by the weighted-average number of shares of Common Stock outstanding during each period. Diluted earnings per share are computed using the weighted average number of shares of Common Stock and the dilutive Common Stock share equivalents outstanding during the period. Dilutive Common Stock share equivalents consist of shares issuable upon the exercise of in-the-money stock options and warrants (calculated using the modified-treasury stock method) and conversion of other securities such as convertible debt or convertible preferred stock. Potential common shares that would be as follows:
| December 31, | June 30, | |
|---|---|---|
| 2023 | 2023 | |
| Weighted average common shares outstanding | 57,608,052 | 6,306,120 |
| Effect of dilutive securities-when applicable: | ||
| Convertible promissory notes | 24,712,177 | 38,998,249 |
| Preferred stock | 11,348 | 11,348 |
| Common stock options | 2,222 | 2,222 |
| Warrants | 5,114,576 | 5,115,207 |
| Fully diluted earnings per share—adjusted weighted-average shares and assumed conversions | 87,448,375 | 50,433,146 |
NOTE 3: PREPAID LICENSE FEE
In April 2022, the Company entered into two-year software license agreement to enable product development. The license fee is prepaid at a rate of $77,850 annually, beginning July 1 of each year. The prepaid license fee is amortized on a straight-line basis over the term of the license agreement, and is included in Development expense in our Statement of Operations. As of December 31, 2023, the prepaid license fee was $38,893.
NOTE 4: DERIVATIVE LIABILITIES
Derivative liability – convertible notes
The Company has certain convertible notes with variable price conversion terms. Upon the issuance of these convertible notes and as a consequence of their conversion features, the convertible notes give rise to embedded derivative liabilities. The Company’s derivative liabilities related to its convertible notes payable have been measured at fair value at December 31, 2023 and June 30, 2023 using the Cox, Ross & Rubinstein Binomial Tree valuation model.
The revaluation of the warrants and convertible debt at each reporting period, as well as the charges associated with issuing additional convertible notes, and warrants with price protection features, resulted in the recognition of a gain of $32,689 and a loss of $33,862 for the six months December 31, 2023 and 2022, respectively in the Company’s consolidated statements of operations, under the caption “Loss in change of fair value of derivative liability”. The fair value of the warrants at December 31, 2023 and June 30, 2023 was $0 and $0, respectively. The fair value of the derivative liability related to the convertible debt at December 31, 2023 and June 30, 2023 is $48,018 and $80,707, respectively, which is reported on the consolidated balance sheet under the caption “Derivative liability”.
The Company has determined its derivative liability to be a Level 3 fair value measurement. The significant assumptions used in the Cox, Ross & Rubinstein Binomial Tree valuation of the derivative are as follows:
| Six Months Ended December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| Effective exercise price | $0.0082 | $0.058 |
| Effective market price | $0.0169 | $0.081 |
| Expected volatility | 268.04% | 256.8% |
| Risk-free interest | 5.59% | 4.41% |
| Expected terms | 60 days | 60 days |
| Expected dividend rate | 0% | 0% |
Changes in the derivative liabilities during the six months ended December 31, 2023 is follows:
| Derivative liabilities at June 30, 2023 | $80,707 |
|---|---|
| Derivative liability expense | - |
| Gain on change in fair value of derivative liabilities | (32,689) |
| Derivative liabilities at December 31, 2023 | $48,018 |
NOTE 5: ACCRUED INTEREST PAYABLE
Changes in accrued interest payable during the six months ended December 31, 2023 is as follows:
| Accrued interest payable at June 30, 2023 | $548,041 |
|---|---|
| Conversion of accrued interest into common stock | (187,805) |
| Interest expense paid in cash | (7,560) |
| Interest expense accrued for the six months ended December 31, 2023 | 159,866 |
| Accrued interest payable at December 31, 2023 | $512,542 |
NOTE 6: CONVERTIBLE NOTES PAYABLE AND NOTES PAYABLE
At December 31, 2023 and June 30, 2023 convertible debentures consisted of the following:
| December 31, | June 30, | |
|---|---|---|
| 2023 | 2023 | |
| Convertible notes payable | $774,502 | $973,576 |
| Discount on convertible notes | (2,437) | - |
| Convertible notes, net | $772,065 | $973,576 |
The Company had convertible promissory notes aggregating $772,065 and $973,576 at December 31, 2023 and June 30, 2023, respectively. The related accrued interest amounted to approximately $259,183 and $324,031 at December 31, 2023 and June 30, 2023, respectively. The convertible notes payable bear interest at rates ranging from 0% to 18% per annum. The convertible notes are generally convertible, at the holders’ option, at rates ranging from $0.0019 to $22,500 per share, as a result of the two reverse stock splits. At December 31, 2023, approximately $694,000 of convertible promissory notes had matured, are in default and remain unpaid. There are no punitive default provisions included in the terms of these convertible promissory notes.
The changes in the convertible notes payable balance are summarized below:
| Convertible payable at June 30, 2023 | $937,576 |
|---|---|
| Convertible notes issued during the six months ended December 31, 2023 | 86,717 |
| Convertible notes repaid in cash | (44,250) |
| Discount related to convertible notes payable | (2,437) |
| Conversion of convertible notes payable into common stock | (205,724) |
| Convertible payable at December 31, 2023 | $772,065 |
For the six months ended December 31, 2023, the following summarizes the conversion of debt for common shares:
| Amount of · Amount of · Conversion | ||||||
|---|---|---|---|---|---|---|
| Shares · Converted · Converted · Conversion · Price | ||||||
| Name | Issued | Principal | Interest | Expense | Total | Per Share |
| Talos Victory Fund | 778,500 | $7,474 | $3,826 | $1,750 | $13,050 | $0.0169 |
| FirstFire | 6,000,000 | 101,400 | - | - | 101,400 | 0.0169 |
| Mast Hill | 17,467,930 | 96,850 | 183,978 | 14,000 | 294,826 | 0.0169 |
| Total | 24,246,430 | $205,724 | $187,805 | $15,750 | $409,276 | $0.0169 |
The Company repaid a convertible note in cash in September 2023. The repayment terms included a premium provision, resulting in a loss on the extinguishment of this debt of $12,035.
A recap of the Gain on extinguishment of debt follows:
| Loss on extinguishment of debt related to payoff of convertible note | $(12,035) |
|---|---|
| $(12,035) |
In February 2022, the Company entered into a Securities Purchase Agreements with three investors pursuant to which each investor purchased a promissory note, The Notes are convertible into shares of the Company’s common stock at a conversion price of $2.43 per share, subject to adjustment as provided therein.
These notes had price protection provisions that allow for the reduction in the current conversion price upon the occurrence of certain events, including the Company’s issuance of common stock or securities convertible into or exercisable for common stock, such as options and warrants, at a price per share less than the conversion price then in effect. For instance, if the Company issues shares of its common stock or options exercisable for or securities convertible into common stock at an effective price per share of common stock less than the exercise price then in effect, the conversion price will be reduced to the effective price of the new issuance.
Due to the price protection features of these convertible notes, the difference between the amount of the fair value of the current conversion price and reduced conversion price calculated using the outstanding principal balances of the notes affected at the time of the conversion at the lower conversion price amounted to $484,460 and is recorded as a deemed dividend with a corresponding increase and decrease in additional paid in capital as of December 31, 2023. Additionally, for the six months ended December 31, 2023, it is reflected as a reduction to the net loss for the year to arrive at the net loss attributable to common shareholders to recognize the effect of the price protection provisions.
Notes Payable
The Company had promissory notes aggregating $581,628 and $380,013 at December 31, 2023 and June 30, 2023, respectively. The related accrued interest amounted to approximately $253,358 and $224,010 at December 31, 2023 and June 30, 2023, respectively. The notes payable bear interest at rates ranging from 0% to 16% per annum and are payable monthly.
Promissory notes totaling $205,000 have matured as of December 31, 2023.
NOTE 7: STOCKHOLDERS’ DEFICIT
Common Stock
At December 31, 2023, the Company had 1,000,000,000 authorized common shares.
At December 31, 2023, the Company has 96,813,626 common shares issued of which 96,501,142 were outstanding, which is net of approximately 312,476 unvested shares issued for the restricted stock awards granted during the year.
Issuances of Common Stock During the Six Months Ended December 31, 2023
During the six months ended December 31, 2023 the Company issued 24,246,430 shares of its common stock related to the conversion of $409,276 of principal and accrued interest, at an average conversion price of $0.0169 per share.
Stock Based Compensation
During the six months ended December 31, 2023 the Company issued 30,960,000 shares of its $0.0001 par value common stock as compensation to its directors and officers. The shares were valued at $520,624, or $0.0168 per share, based on the share price at the time of the transactions. The shares vested during the period were issued at different dates, hence, different quoted prices. The grant-date quoted price of the shares that vested for directors and officers ranged from $0.0168 to $0.0169.
During the six months ended December 31, 20236,129,999 shares of its $0.0001 par value common stock vested to its consultants, as compensation under separate consulting agreements. The shares were valued at $306,100, or $0.05 per share. The shares vested during the period were issued at different dates, hence different quoted prices. The grant-date quoted price of the shares that vested for consultants ranged from $0.0168 to $0.3100. Consultants were granted stock awards in January 2023, at a time when stock prices were trading $0.31, Some of these granted stocks were vested in Q2 2024. Directors, officers, and employees did not receive a stock award on the same date.
During the six months ended December 31, 2023 the Company issued 5,320,000 shares of its $0.0001 par value common stock as compensation to its employees. The shares were valued at $89,408, or $0.0168 per share, based on the share price at the time of the transaction.
NOTE 7: STOCKHOLDERS’ DEFICIT**, continued**
Preferred Stock
Series A and B issued and outstanding shares of the Company’s convertible preferred stock have a par value of $0.001. All classes rank(ed) prior to any class or series of the Company’s common stock as to the distribution of assets upon liquidation, dissolution or winding up of the Company or as to the payment of dividends. All preferred stock shall have no voting rights except if the subject of such vote would reduce the amount payable to the holders of preferred stock upon liquidation or dissolution of the company and cancel and modify the conversion rights of the holders of preferred stock as defined in the certificate of designations of the respective series of preferred stock.
Series A Convertible Preferred Stock
The Series A Preferred Stock has a stated value of $750.00 per share. Each one share of Series A Preferred Stock is convertible into one (1) share of Common Stock. In the event the Common Stock price per share is lower than $0.10 (ten cents) per share then the Conversion shall be set at $0.035 per share. The Common Stock shares are governed by Lock-Up/Leak-Out Agreements.
Series B Convertible Preferred Stock
Thirty million (30,000,000) shares of preferred stock were designated as a new Series B Preferred stock in April 2016. This new Series B Preferred Stock has a $0.001 par value, and each 300 shares is convertible into one share of the Company’s common stock, with a stated value of $375 per share.
Series C Convertible Preferred Stock
Thirty thousand (30,000) shares of preferred stock were designated as Series C Preferred stock in October 2023. This Series C Preferred Stock has a $0.001 par value, and each share is convertible into the Company’s common stock at a conversion price of $0.075 per share, with a stated value of $100 per share. There were no Series C Convertible Preferred shares outstanding as of December 31, 2023.
Series AA Convertible Preferred Stock
In March 2018, the Company authorized and issued one share of Series AA convertible preferred stock which provides for the holder to vote on all matters as a class with the holders of Common Stock and each share of Series AA Convertible Preferred Stock shall be entitled to 51% of the common votes on any matters requiring a shareholder vote of the Company. Each one share of Series AA Convertible Preferred Stock is convertible into one (1) share of Common Stock. Mark Lucky, our CEO and CFO, is the holder of the one share of Series AA Convertible Preferred Stock.
Common Stock Warrants
In September 2022 we issued 138,667 warrants with a five year life, and a fixed exercise price of $1.35 per share, as part of a modification to three outstanding convertible notes payable. The Company evaluated these amendments under ASC 470-50, “Debt - Modification and Extinguishment”, and concluded that the issuance of these warrants in exchange for deferring the interim interest payments that were due resulted in significant and consequential changes to the economic substance of the debt and thus resulted in accounting for these modifications as an extinguishment of the debt. The Company recorded a loss of extinguishment of debt of $504,925. These warrants had price protection provisions that allow for the reduction in the current exercise price upon the occurrence of certain events, including the Company’s issuance of common stock or securities convertible into or exercisable for common stock, such as options and warrants, at a price per share less than the exercise price then in effect. For instance, if the Company issues shares of its common stock or options exercisable for or securities convertible into common stock at an effective price per share of common stock less than the exercise price then in effect, the exercise price will be reduced to the effective price of the new issuance. Simultaneously with any reduction to the exercise price, the number of shares of common stock that may be purchased upon exercise of each of these warrants shall be increased proportionately, so that after such adjustment the aggregate exercise price payable for the adjusted number of warrants shall be the same as the aggregate exercise price in effect immediately prior to such adjustment.
Due to the price protection features of these warrants, the Company issued 5,048,426 warrant shares to these warrant holders. The difference between the amount of the fair value of the current exercise price and reduced exercise price was treated as deemed dividend.
A summary of the status of the Company’s outstanding common stock warrants as of December 31, 2023 and changes during the fiscal year ending on that date is as follows:
| Number of | Weighted Average | |
|---|---|---|
| Warrants | Exercise Price | |
| Common Stock Warrants | ||
| Balance at beginning of year | 5,115,207 | $0.025 |
| Granted | - | - |
| Exercised | - | - |
| Forfeited | (631) | 10.395 |
| Balance at end of period | 5,114,576 | $0.023 |
| Warrants exercisable at end of period | 5,114,576 | $0.023 |
NOTE 7: STOCKHOLDERS’ DEFICIT**, continued**
The following table summarizes information about common stock warrants outstanding at December 31, 2023:
| Warrants Outstanding · Warrants Exercisable | |||||
|---|---|---|---|---|---|
| Range of Exercise Price | NumberOutstanding At December 31,2023 | WeightedAverageRemainingContractual Life | WeightedAverageExercisePrice | NumberExercisable At December 31,2023 | WeightedAverageExercisePrice |
| $0.0169 | 5,112,426 | 3.67 Years | $0.0169 | 5,112,426 | $0.0169 |
| 12.285 | 1,339 | 0.75 Years | 12.285 | 1,339 | 12.285 |
| 20.385 | 811 | 0.75 Years | 20.385 | 811 | 20.385 |
| 5,114,576 | 3.67 Years | $0.023 | 5,114,576 | $0.023 | |
Note 8 -STOCK-BASED COMPENSATION
The Company adopted a Stock Incentive Plan on April 18, 2021. This plan is intended to provide incentives which will attract and retain highly competent persons at all levels as employees of the Company, as well as independent contractors providing consulting or advisory services to the Company, by providing them opportunities to acquire the Company’s common stock or to receive monetary payments based on the value of such shares pursuant to Awards issued. While the 2021 Plan terminates 10 years after the adoption date, issued options have their own schedule of termination. Options to acquire shares of common stock may be granted at no less than fair market value on the date of grant. Upon exercise, shares of new common stock are issued by the Company.
Under the 2021 Stock Incentive Plan, the Company has issued options to purchase 11,852 shares at an average price of $20.25 with a fair value of $0.00. For the six months ended December 31, 2023 and 2022, the Company did not issue any options to purchase shares, respectively. Upon exercise, shares of new common stock are issued by the Company.
For the six months ended December 31, 2023 and 2022, the Company did not recognize any, respectively, of non-cash compensation expense (which would be included in General and Administrative expense in the accompanying Consolidated Statement of Operations) determined by application of a binomial option pricing model with the following inputs: exercise price, dividend yields, risk-free interest rate, and expected annual volatility. As of December 31, 2023, the Company had no unrecognized pre-tax non-cash compensation expense. The Company used straight-line amortization of compensation expense over the one-year requisite service or vesting period of the grant. The Company recognizes forfeitures as they occur. There are options to purchase approximately 2,222 shares that have vested as of December 31, 2023.
The Company uses a binomial option pricing model to estimate the fair value of its stock option awards and warrant issuances. The calculation of the fair value of the awards using the binomial option-pricing model is affected by the Company’s stock price on the date of grant as well as assumptions regarding the following:
| Six months ended December 31, | Year ended June 30, | |||||
| 2023 | 2023 | |||||
| Expected volatility | - | % | - | % | ||
|---|---|---|---|---|---|---|
| Expected term | - | - | ||||
| Risk-free interest rate | - | % | - | % | ||
| Forfeiture Rate | - | % | - | % | ||
| Expected dividend yield | - | % | - | % | ||
The expected volatility was determined with reference to the historical volatility of the Company’s stock. The Company uses historical data to estimate option exercise and employee termination within the valuation model. The expected term of options granted represents the period of time that options granted are expected to be outstanding. The risk-free interest rate for periods within the contractual life of the option is based on the U.S. Treasury rate in effect at the time of grant.
Note 8 -STOCK-BASED COMPENSATION, continued
A summary of the status of the Company’s outstanding stock options as of December 31, 2023 and June 30, 2023 and changes during the periods ending on that date is as follows:
| Weighted Average · Grant Date · Aggregate · WeightedAverage | ||||||
|---|---|---|---|---|---|---|
| Exercise · Fair · Intrinsic · Remaining | ||||||
| Shares · Price · Value · Value · Term (Yrs) | ||||||
| Options | ||||||
| At June 30, 2023 | 2,222 | $27.00 | $ | - | $0 | 2.33 |
| Granted | - | - | - | - | - | |
| Exercised | - | - | - | - | - | |
| Forfeiture and cancelled | - | - | - | - | ||
| At December 31, 2023 | 2,222 | $27.00 | $ | - | $0 | 2.33 |
The following table summarizes information about employee stock options outstanding at December 31, 2023:
| Outstanding Options · Vested Options | ||||||
|---|---|---|---|---|---|---|
| Number · Number | ||||||
| Outstanding · Weighted · Weighted · Exercisable · Weighted · Weighted | ||||||
| at · Averaged · Averaged · at · Averaged · Averaged | ||||||
| December 31, · Remaining · Exercise · December 31, · Exercise · Remaining | ||||||
| Range of Exercise Price | 2023 | Life | Price | 2023 | Price | Life |
| $27.00 | 2,222 | 2.33 | $27.00 | 2,222 | $27.00 | 2.33 |
| Outstanding options | 2,222 | 2.33 | $27.00 | 2,222 | $27.00 | 2.33 |
As of December 31, 2023, the Company had approximately $0 of unrecognized pre-tax non-cash compensation expense.
Restricted Stock Awards
Restricted stock awards are awards of common stock that are subject to restrictions on transfer and to a risk of forfeiture if the holder leaves the Company before the restrictions lapse or the vesting conditions of the award are not met. The holder of a vested restricted stock award is generally entitled at all times on and after the date of issuance of the restricted shares to exercise the rights of a shareholder of the Company, including the right to vote the shares. The value of stock awards that vest over time was established by the market price on the date of its grant. A summary of the Company’s restricted stock activity for the six months ended December 31, 2023 is presented in the following table:
| Weighted | |||
|---|---|---|---|
| Average | |||
| Grant Date | |||
| Shares · Fair Value | |||
| Unvested at June 30, 2023 | 7,297,475 | $0.06 | |
| Granted | 35,425,000 | $0.0169 | |
| Forfeited | - | $ | - |
| Vested | (42,409,999) | $0.022 | |
| Unvested at December 31, 2023 | 312,476 | $0.289 | |
Unrecognized compensation expense related to outstanding restricted stock awards to employees and directors as of December 31, 2023 was $90,208 and is expected to be recognized over a weighted average period of 0.5 years. The recognition of expense related to vested shares is accounted for as stock-based consulting expense and stock-based compensation expense for a total of $916,132 for the six months ended December 31, 2023.
NOTE 9: RELATED PARTY TRANSACTIONS
Equity transactions with related parties are described in Note 7.
From time to time we have borrowed operating funds from Mr. Mark Lucky, our Chief Executive Officer and from certain Directors, for working capital. The advances were payable upon demand and were interest free. At December 31, 2023 there was $139,633 outstanding of such advances made to the Company.
NOTE 10 - ACCRUED PAYROLL
Accrued payroll consist of the following at:
| December 31 | June 30 | |
|---|---|---|
| 2023 | 2023 | |
| Accrued Payroll - officers | $1,042,362 | $900,846 |
| Accrued payroll - staff | 657,017 | 471,033 |
| $1,699,379 | $1,371,879 |
NOTE 11: COMMITMENTS AND CONTINGENCIES
Operating Leases
The Company operates virtually, with no office space rented. The Company has no future minimum annual payments under non-cancelable operating leases at December 31, 2023.
Contingencies
The Company accounts for contingent liabilities in accordance with Accounting Standards Codification (“ASC”) Topic 450,Contingencies. This guidance requires management to assess potential contingent liabilities that may exist as of the date of the financial statements to determine the probability and amount of loss that may have occurred, which inherently involves an exercise of judgment. If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed. For loss contingencies considered remote, no accrual or disclosures are generally made. Management has assessed potential contingent liabilities as of December 31, 2023, and based on the assessment there are no probable loss contingencies requiring accrual or disclosures within its financial statements.
License Contingent Consideration
Our license agreements with The MITRE Corporation include provisions for a royalty payment on revenues collected of 6%. As of December 31, 2023, we have not generated any revenue related to these license agreements.
Legal Claims
The Company is subject to litigation, claims, investigations, and audits arising from time to time in the ordinary course of business. Although legal proceedings are inherently unpredictable, the Company believes that it has valid defenses with respect to any matters currently pending against the Company and intends to defend itself vigorously. The outcome of these matters, individually and in the aggregate, is not expected to have a material impact on the Company’s cash flows, results of operations, or financial position.
NOTE 12: SUBSEQUENT EVENTS
In January 2024 our consultants vested 5,037,500 shares of our $0.0001 par value common stock to three employees as compensation, valued at $94,958, or an average price per share of $0.0189.
In January 2024 the Company issued 4,300,000 shares of its $0.0001 par value common stock upon the conversion of principal and interest of $74,243 of its outstanding promissory notes, valued at $0.0173 per share.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.